EC 1.1.1.231: 15-hydroxyprostaglandin-I dehydrogenase (NADP+)
This is an abbreviated version!
For detailed information about 15-hydroxyprostaglandin-I dehydrogenase (NADP+), go to the full flat file.
Reaction
Synonyms
dehydrogenase, prostacyclin, NADP+-dependent PGI2-specific 15-hydroxyprostaglandin dehydrogenase, NADP-linked 15-hydroxyprostaglandin (prostacyclin) dehydrogenase, PG I2 dehydrogenase, prostacyclin dehydrogenase
ECTree
Advanced search results
Substrates Products
Substrates Products on EC 1.1.1.231 - 15-hydroxyprostaglandin-I dehydrogenase (NADP+)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
REACTION DIAGRAM
(5Z,13E)-(15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate + NADP+
(5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate + NADPH
4-benzoylpyridine + NADP+
?
-
Substrates: recombinant forms CHCR1, CHCR2
Products: -
Products: -
?
6-keto-prostaglandin F1alpha + NADP+
6,15-diketoprostaglandin F2alpha + NADPH
-
Substrates: at 1.8% the reaction rate of prostaglandin I2
Products: -
Products: -
?
menadione + NADP+
?
-
Substrates: more rapid reaction than with prostacyclin
Products: -
Products: -
?
phenanthrene quinone + NADP+
?
-
Substrates: more rapid reaction than with prostacyclin
Products: -
Products: -
?
prostaglandin B1 + NADP+
15-ketoprostaglandin B1 + NADPH + H+
-
Substrates: at 8% the reaction rate of prostaglandin I2
Products: -
Products: -
?
prostaglandin F2alpha + NAD+
15-ketoprostaglandin F2alpha + NADH + H+
-
Substrates: -
Products: -
Products: -
?
pyridine-4-carboxaldehyde + NADP+
?
-
Substrates: recombinant forms CHCR1, CHCR2
Products: -
Products: -
?
(5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate + NADPH
-
Substrates: i.e. prostaglandin I2, prostacyclin
Products: the product is not stable and not available for analysis of the reverse reaction
Products: the product is not stable and not available for analysis of the reverse reaction
?
(5Z,13E)-(15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate + NADP+
(5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate + NADPH
-
Substrates: i.e. prostaglandin I2, prostacyclin
Products: i.e. 15-keto prostaglandin I2
Products: i.e. 15-keto prostaglandin I2
?
(5Z,13E)-(15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dienoate + NADP+
(5Z,13E)-6,9alpha-epoxy-11alpha-hydroxy-15-oxoprosta-5,13-dienoate + NADPH
-
Substrates: -
Products: -
Products: -
?
4-nitrobenzoate + NADPH
-
Substrates: recombinant forms CHCR1, CHCR2
Products: -
Products: -
?
4-nitrobenzaldehyde + NADP+
4-nitrobenzoate + NADPH
-
Substrates: more rapid reaction than with prostacyclin
Products: -
Products: -
?
15-ketoprostaglandin E2 + NADPH + H+
-
Substrates: -
Products: -
Products: -
?
prostaglandin E2 + NADP+
15-ketoprostaglandin E2 + NADPH + H+
-
Substrates: at 4% the reaction rate of prostaglandin I2
Products: -
Products: -
?
15-ketoprostaglandin F2alpha + NADPH + H+
-
Substrates: -
Products: -
Products: -
?
prostaglandin F2alpha + NADP+
15-ketoprostaglandin F2alpha + NADPH + H+
-
Substrates: at 2.2% the reaction rate of prostaglandin I2
Products: -
Products: -
?
?
-
-
Substrates: comparison of 3 15-hydroxyproastaglandin dehydrogenases with varying amounts of 9-ketoprostaglandin reductase activity
Products: -
Products: -
?
additional information
?
-
-
Substrates: enzyme catalyzes reduction of 9-keto group in prostaglandin E2 at less than 1% the rate of prostaglandin I2 oxidation
Products: -
Products: -
?

results (
results (
top





